Skip to main content
BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.900
0.00 (0.00%)
Apr 1, 2025, 4:32 PM IDT

BioLineRx Revenue

BioLineRx had revenue of $4.94M USD in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $21.99M. In the year 2023, BioLineRx had annual revenue of $4.80M.

Revenue (ttm)
$21.99M
Revenue Growth
n/a
P/S Ratio
0.22
Revenue / Employee
$278.37K
Employees
79
Market Cap
42.42M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 60.26B
Danel (Adir Yeoshua) 2.77B
Kamada 586.24M
Bait Bakfar 103.40M
Novolog (Pharm-Up 1966) 2.02B
Ilex Medical 982.96M
BrainsWay 149.39M
SofWave Medical 217.27M
Revenue Rankings

BioLineRx News

More News